Suchergebnisse - "Hu, Huabin"

PubPharm (6)

1

China special issue on gastrointestinal tumors-Radiological features of pathological complete response in mismatch repair deficient colorectal cancer after neoadjuvant PD-1 blockade : A post hoc analysis of the PICC phase II trial

enthalten in: International journal of cancer | 2023

von Cao, W. | Hu, H. | Li, J. | +11

2

Capecitabine maintenance therapy in metastatic colorectal cancer patients with no evidence of disease : CAMCO trial

enthalten in: Future oncology (London, England) | 2023

von Ling, J. | Lin, Z. | Shi, L. | +8

3

Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer : Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy

enthalten in: Diseases of the colon and rectum | 2023

von Zhang, J. | Li, J. | Huang, M. | +6

4

Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC) : a single-centre, parallel-group, non-comparative, randomised, phase 2 trial

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Hu, H. | Kang, L. | Zhang, J. | +27

CommentIn: Lancet Gastroenterol Hepatol. 2022 Jan;7(1):4-6. - PMID 34688372

5

Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal Cancer : The FOCULM Multicenter Phase II Trial

enthalten in: The oncologist | 2021

von Hu, H. | Wang, K. | Huang, M. | +25

6

Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer

enthalten in: Clinical colorectal cancer | 2019

von Zhang, J. | Huang, M. | Cai, Y. | +18

1
[1]